Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer

Lyu, D; Liu, BL; Lan, B; Sun, XY; Li, LX; Zhai, JT; Qian, HL; Ma, F

Ma, F (通讯作者),Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Beijing 100021, Peoples R China.;Ma, F (通讯作者),Peking Union Med Coll, Beijing 100021, Peoples R China.

CHINESE JOURNAL OF CANCER RESEARCH, 2022; 34 (4): 343

Abstract

Objective: The mechanism of acquired gene mutation plays a major role in resistance to endocrine therapy in hormone receptor (HR)-positive advanced br......

Full Text Link